TOX is a critical regulator of tumour-specific T cell differentiation

被引:726
|
作者
Scott, Andrew C. [1 ,2 ]
Dundar, Friederike [3 ,4 ]
Zumbo, Paul [3 ,4 ]
Chandran, Smita S. [5 ,6 ]
Klebanoff, Christopher A. [5 ,6 ,7 ,8 ]
Shakiba, Mojdeh [1 ,3 ]
Trivedi, Prerak [1 ]
Menocal, Laura [1 ,2 ]
Appleby, Heather [1 ]
Camara, Steven [1 ]
Zamarin, Dmitriy [5 ,7 ]
Walther, Tyler [7 ]
Snyder, Alexandra [7 ]
Femia, Matthew R. [5 ,6 ]
Comen, Elizabeth A. [7 ,8 ]
Wen, Hannah Y. [9 ]
Hellmann, Matthew D. [5 ,7 ,8 ]
Anandasabapathy, Niroshana [2 ,10 ]
Liu, Yong [10 ]
Altorki, Nasser K. [11 ]
Lauer, Peter [12 ]
Levy, Olivier [1 ]
Glickman, Michael S. [1 ,2 ]
Kaye, Jonathan [13 ]
Betel, Doron [4 ,14 ,15 ]
Philip, Mary [1 ,16 ]
Schietinger, Andrea [1 ,2 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA
[3] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA
[4] Weill Cornell Med, Appl Bioinformat Core, New York, NY USA
[5] Parker Inst Canc Immunotherapy, New York, NY 10017 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med Coll, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
[10] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[11] New York Presbyterian Hosp, Dept Cardiothorac Surg, Weill Cornell Med, New York, NY USA
[12] Aduro Biotech Inc, Berkeley, CA USA
[13] Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA
[14] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[15] Weill Cornell Med, Inst Computat Biomed, New York, NY USA
[16] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN USA
关键词
EXHAUSTION; PROMOTES; DYSFUNCTION; ANTIGEN; AUTOIMMUNITY; EXPRESSION; GENERATION; PROTEINS; EFFECTOR; PROGRAM;
D O I
10.1038/s41586-019-1324-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states(1-6). Here we identify the nuclear factor TOX as a crucial regulator of the differentiation of tumour-specific T (TST) cells. We show that TOX is highly expressed in dysfunctional TST cells from tumours and in exhausted T cells during chronic viral infection. Expression of TOX is driven by chronic T cell receptor stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induced a transcriptional program associated with T cell exhaustion. Conversely, deletion of Tox in TST cells in tumours abrogated the exhaustion program: Tox-deleted TST cells did not upregulate genes for inhibitory receptors (such as Pdcd1, Entpd1, Havcr2, Cd244 and Tigit), the chromatin of which remained largely inaccessible, and retained high expression of transcription factors such as TCF-1. Despite their normal, 'non-exhausted' immunophenotype, Tox-deleted TST cells remained dysfunctional, which suggests that the regulation of expression of inhibitory receptors is uncoupled from the loss of effector function. Notably, although Tox-deleted CD8 T cells differentiated normally to effector and memory states in response to acute infection, Tox-deleted TST cells failed to persist in tumours. We hypothesize that the TOX-induced exhaustion program serves to prevent the overstimulation of T cells and activation-induced cell death in settings of chronic antigen stimulation such as cancer.
引用
收藏
页码:270 / +
页数:27
相关论文
共 50 条
  • [41] Nodal interferon exposure drives tumour-specific tolerance
    Caroline Barranco
    Nature Reviews Cancer, 2022, 22 : 377 - 377
  • [42] Towards personalized, tumour-specific, therapeutic vaccines for cancer
    Zhuting Hu
    Patrick A. Ott
    Catherine J. Wu
    Nature Reviews Immunology, 2018, 18 : 168 - 182
  • [43] Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens
    Wolf, Melissa M.
    Rathmell, W. Kimryn
    de Cubas, Aguirre A.
    NATURE REVIEWS NEPHROLOGY, 2023, 19 (07) : 440 - 450
  • [44] Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
    Coulson, JM
    Stanley, J
    Woll, PJ
    BRITISH JOURNAL OF CANCER, 1999, 80 (12) : 1935 - 1944
  • [45] Generation of tumour-specific cytotoxic T-lymphocytes from peripheral blood of colorectal cancer patients for adoptive t-cell transfer
    Corluccio, S.
    Delbue, S.
    Ferrante, P.
    Bregni, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S33 - S33
  • [46] Expression of tumour-specific antigens underlies cancer immunoediting
    Michel DuPage
    Claire Mazumdar
    Leah M. Schmidt
    Ann F. Cheung
    Tyler Jacks
    Nature, 2012, 482 : 405 - 409
  • [47] Expression of tumour-specific antigens underlies cancer immunoediting
    DuPage, Michel
    Mazumdar, Claire
    Schmidt, Leah M.
    Cheung, Ann F.
    Jacks, Tyler
    NATURE, 2012, 482 (7385) : 405 - U1512
  • [48] Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens
    Melissa M. Wolf
    W. Kimryn Rathmell
    Aguirre A. de Cubas
    Nature Reviews Nephrology, 2023, 19 : 440 - 450
  • [49] Towards personalized, tumour-specific, therapeutic vaccines for cancer
    Hu, Zhuting
    Ott, Patrick A.
    Wu, Catherine J.
    NATURE REVIEWS IMMUNOLOGY, 2018, 18 (03) : 168 - 182
  • [50] TUMOUR-SPECIFIC IMMUNITY AGAINST SPONTANEOUS RAT TUMOURS
    BALDWIN, RW
    INTERNATIONAL JOURNAL OF CANCER, 1966, 1 (03) : 257 - +